Analyst Ratings for Spruce Biosciences, Inc. (SPRB)
SPRB Rating Summary
SPRB Price Target Summary
- Highest: $230.00 (Oppenheimer)
- Lowest: $123.00 (Guggenheim)
- Average: $162.57
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$162.57 (+233.4%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 79%
Rating Score: 7.5 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/16/2026 | Guggenheim | Debjit Chattopadhyay | New Coverage | Buy (N/A) |
123.00 (N/A) |
49.91 (48.76) |
-2.3% | Details |
| 6/8/2026 | Jones Trading | Catherine Novack | New Coverage | Buy (N/A) |
135.00 (N/A) |
50.43 (48.76) |
-3.31% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


